A1 Journal article (refereed)
NGS of brush cytology samples improves the detection of high-grade dysplasia and cholangiocarcinoma in patients with primary sclerosing cholangitis : A retrospective and prospective study (2024)


Boyd, S., Mustamäki, T., Sjöblom, N., Nordin, A., Tenca, A., Jokelainen, K., Rantapero, T., Liuksiala, T., Lahtinen, L., Kuopio, T., Kytölä, S., Mäkisalo, H., Färkkilä, M., & Arola, J. (2024). NGS of brush cytology samples improves the detection of high-grade dysplasia and cholangiocarcinoma in patients with primary sclerosing cholangitis : A retrospective and prospective study. Hepatology Communications, 8(4), Article e0415. https://doi.org/10.1097/HC9.0000000000000415


JYU authors or editors


Publication details

All authors or editorsBoyd, Sonja; Mustamäki, Taru; Sjöblom, Nelli; Nordin, Arno; Tenca, Andrea; Jokelainen, Kalle; Rantapero, Tommi; Liuksiala, Thomas; Lahtinen, Laura; Kuopio, Teijo; et al.

Journal or seriesHepatology Communications

eISSN2471-254X

Publication year2024

Publication date29/03/2024

Volume8

Issue number4

Article numbere0415

PublisherWolters Kluwer Health

Publication countryUnited States

Publication languageEnglish

DOIhttps://doi.org/10.1097/HC9.0000000000000415

Publication open accessOpenly available

Publication channel open accessOpen Access channel

Publication is parallel published (JYX)https://jyx.jyu.fi/handle/123456789/94478

Publication is parallel publishedhttp://hdl.handle.net/10138/574330


Abstract

Background:
Biliary dysplasia, a precursor of cholangiocarcinoma (CCA), is a common complication of primary sclerosing cholangitis. Patients with high-grade dysplasia (HGD) or early CCA who have received oncological treatment are candidates for liver transplantation. The preoperative diagnosis of CCA or HGD is challenging, and the sensitivity of biliary brush cytology (BC) is limited.

Methods:
By using next-generation sequencing (NGS), we retrospectively analyzed archived tissue samples (n=62) obtained from explanted liver tissue and CCA samples to identify oncogenic mutations that occur during primary sclerosing cholangitis carcinogenesis. BC samples were prospectively collected from patients with primary sclerosing cholangitis (n=97) referred for endoscopic retrograde cholangiography to measure the diagnostic utility of NGS combined with BC compared with traditional cytology alone.

Results:
Mutations in KRAS, GNAS, FLT3, RNF43, TP53, ATRX, and SMAD4 were detected in archived CCA or HGD samples. KRAS, GNAS, TP53, CDKN2A, FBXW7, BRAF, and ATM mutations were detected in prospectively collected brush samples from patients with histologically verified CCA or HGD. One patient with low-grade dysplasia in the explanted liver had KRAS and GNAS mutations in brush sample. No mutations were observed in brush samples or archived tissues in liver transplantation cases without biliary neoplasia. While KRAS mutations are common in biliary neoplasms, they were also observed in patients without biliary neoplasia during surveillance.

Conclusions:
In summary, NGS of BC samples increased the sensitivity of detecting biliary neoplasia compared with traditional cytology. Performing NGS on BC samples may help diagnose HGD or early CCA, benefiting the timing of liver transplantation.


Keywordsliver diseasescancerous diseasessclerosing cholangitiscarcinomasdysplasiadiagnosticsliver transplantationtreatment methodscell biology


Contributing organizations


Ministry reportingYes

Preliminary JUFO rating1


Last updated on 2024-25-04 at 12:29